There has also been a mechanistic report that donepezil is involved in the activation of nicotinic acetylcholine-receptors (nAChR), which affects the treatment of neuronal death and cognitive impairment after TBI [31]. The gene discussed is CHRNA4; the disease is Cognitive impairment.